[Optimal prevention and pharmacotheraphy in stable angina pectoris].
Klinika Chorób Serca i Naczyń, Instytut Kardiologii, Uniwersytet Jagielloński Collegium Medicum, Krakowski Szpital Specjalistyczny im. Jana Pawla II, Kraków. ppodolec@interia.pl
Piotr
P
Podolec
Grzegorz
G
Kopeć
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009204:Myocardial Revascularization / Q000379:methods; D009566:Nitrates / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011788:Quality of Life
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D009566:Nitrates